Amgen Inc. (NASDAQ: AMGN) is one of the 11 Cheap Quarterly Dividend Stocks to Buy Right Now, offering income investors a strong portfolio with over two dozen brands, including blockbuster drugs with over $1 billion in annual sales.

Amgen Inc. (NASDAQ: AMGN) offers medicines across various therapeutic areas, such as Repatha for heart attack risk reduction, Evenity and Prolia for bone health, and Otezla for plaque psoriasis treatment.

In the second quarter, Amgen Inc. (NASDAQ: AMGN) reported revenue of $9.2 billion, a 9% increase from the prior year, with adjusted earnings per share rising by 21%. The company also boasts 14 consecutive years of dividend growth, currently offering a quarterly dividend of $2.38 per share and a 3.32% dividend yield.

While Amgen (AMGN) is a solid dividend pick, some believe other AI stocks may offer greater upside potential with lower downside risk. For those seeking undervalued AI stocks, the best short-term AI stock may be worth considering for investment opportunities.

Read more at Yahoo Finance: Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?